For the past ten years I have worked as a Scientist and Product Manager at Advanced Targeting Systems. I participate in the conjugation and quality control of a variety of research materials. This responsibility includes conjugating proteins, peptides, and antibodies to various tags and payloads. It also includes assay design and implementation for both quality control on in-house production, but also for external customers who use our contract research service partner, CytoLogistics. I am experienced in contract research services centered around cell-based assays, including but not limited to ELISA, cytotoxicity, receptor binding, flow cytometry, drug screening, conjugation, and interfacing with service customers to complete their project requirements. I have developed and produced many recombinant proteins in both E. coli and mammalian cells, including the initial theory and design, to the hands-on molecular cloning, production, purification, and testing. My mentor Dr. Douglas Lappi, (Co-Founder and President Emeritus of ATS), successfully advanced a targeted toxin, SP-SAP, into human clinical trial for the treatment of chronic pain in terminal cancer patients who are unresponsive to opioids. It was my responsibility in this process to perform quality control assays and oversee the production of test material and completion of periodic stability assays on the drug.